2-[3-[(5R,11R)-14-benzyl-11-[(4-hydroxyphenyl)methyl]-5-(1H-indol-3-ylmethyl)-3,6,9,12,15-pentaoxo-1,4,7,10,13-pentazacyclopentadec-2-yl]propyl]guanidine

C37H43N9O6 — CID 140752504

IUPAC2-[3-[(5R,11R)-14-benzyl-11-[(4-hydroxyphenyl)methyl]-5-(1H-indol-3-ylmethyl)-3,6,9,12,15-pentaoxo-1,4,7,10,13-pentazacyclopentadec-2-yl]propyl]guanidine
SMILESNC(N)=NCCCC1NC(=O)C(Cc2ccccc2)NC(=O)[C@@H](Cc2ccc(O)cc2)NC(=O)CNC(=O)[C@@H](Cc2c[nH]c3ccccc23)NC1=O
InChIInChI=1S/C37H43N9O6/c38-37(39)40-16-6-11-28-34(50)46-31(19-24-20-41-27-10-5-4-9-26(24)27)33(49)42-21-32(48)43-29(18-23-12-14-25(47)15-13-23)35(51)45-30(36(52)44-28)17-22-7-2-1-3-8-22/h1-5,7-10,12-15,20,28-31,41,47H,6,11,16-19,21H2,(H,42,49)(H,43,48)(H,44,52)(H,45,51)(H,46,50)(H4,38,39,40)/t28?,29-,30?,31-/m1/s1
InChIKeyMFIQGOQLQIPLCK-VWKIIYCGSA-N
MW709.81 g/mol
LogP0.02
Rot. Bonds10

About 2-[3-[(5R,11R)-14-benzyl-11-[(4-hydroxyphenyl)methyl]-5-(1H-indol-3-ylmethyl)-3,6,9,12,15-pentaoxo-1,4,7,10,13-pentazacyclopentadec-2-yl]propyl]guanidine

2-[3-[(5R,11R)-14-benzyl-11-[(4-hydroxyphenyl)methyl]-5-(1H-indol-3-ylmethyl)-3,6,9,12,15-pentaoxo-1,4,7,10,13-pentazacyclopentadec-2-yl]propyl]guanidine (PubChem CID 140752504) has the molecular formula C37H43N9O6 and a molecular weight of 709.81 g/mol. Its IUPAC name is 2-[3-[(5R,11R)-14-benzyl-11-[(4-hydroxyphenyl)methyl]-5-(1H-indol-3-ylmethyl)-3,6,9,12,15-pentaoxo-1,4,7,10,13-pentazacyclopentadec-2-yl]propyl]guanidine.

Molecular Properties

Compound Name2-[3-[(5R,11R)-14-benzyl-11-[(4-hydroxyphenyl)methyl]-5-(1H-indol-3-ylmethyl)-3,6,9,12,15-pentaoxo-1,4,7,10,13-pentazacyclopentadec-2-yl]propyl]guanidine
PubChem CID140752504
Molecular FormulaC37H43N9O6
Molecular Weight709.81 g/mol
Exact Mass709.33
IUPAC Name2-[3-[(5R,11R)-14-benzyl-11-[(4-hydroxyphenyl)methyl]-5-(1H-indol-3-ylmethyl)-3,6,9,12,15-pentaoxo-1,4,7,10,13-pentazacyclopentadec-2-yl]propyl]guanidine
SMILESNC(N)=NCCCC1NC(=O)C(Cc2ccccc2)NC(=O)[C@@H](Cc2ccc(O)cc2)NC(=O)CNC(=O)[C@@H](Cc2c[nH]c3ccccc23)NC1=O
InChIInChI=1S/C37H43N9O6/c38-37(39)40-16-6-11-28-34(50)46-31(19-24-20-41-27-10-5-4-9-26(24)27)33(49)42-21-32(48)43-29(18-23-12-14-25(47)15-13-23)35(51)45-30(36(52)44-28)17-22-7-2-1-3-8-22/h1-5,7-10,12-15,20,28-31,41,47H,6,11,16-19,21H2,(H,42,49)(H,43,48)(H,44,52)(H,45,51)(H,46,50)(H4,38,39,40)/t28?,29-,30?,31-/m1/s1
InChIKeyMFIQGOQLQIPLCK-VWKIIYCGSA-N
XLogP0.02
TPSA245.92 Ų
H-Bond Donors9
H-Bond Acceptors7
Rotatable Bonds10
Heavy Atoms52
Complexity

Lipinski Rule of Five

2 violations

RuleValue
MW ≤ 500709.81
LogP ≤ 50.02
H-Bond Donors ≤ 59
H-Bond Acceptors ≤ 107

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'Aliphatic_long_chain', 'substructure': 'N/A'}, {'alert_name': 'imine_1', 'substructure': 'N/A'}, {'alert_name': 'imine_2', 'substructure': 'N/A'}

Analyze 2-[3-[(5R,11R)-14-benzyl-11-[(4-hydroxyphenyl)methyl]-5-(1H-indol-3-ylmethyl)-3,6,9,12,15-pentaoxo-1,4,7,10,13-pentazacyclopentadec-2-yl]propyl]guanidine with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of 2-[3-[(5R,11R)-14-benzyl-11-[(4-hydroxyphenyl)methyl]-5-(1H-indol-3-ylmethyl)-3,6,9,12,15-pentaoxo-1,4,7,10,13-pentazacyclopentadec-2-yl]propyl]guanidine?
The IUPAC name of 2-[3-[(5R,11R)-14-benzyl-11-[(4-hydroxyphenyl)methyl]-5-(1H-indol-3-ylmethyl)-3,6,9,12,15-pentaoxo-1,4,7,10,13-pentazacyclopentadec-2-yl]propyl]guanidine (CID 140752504) is 2-[3-[(5R,11R)-14-benzyl-11-[(4-hydroxyphenyl)methyl]-5-(1H-indol-3-ylmethyl)-3,6,9,12,15-pentaoxo-1,4,7,10,13-pentazacyclopentadec-2-yl]propyl]guanidine.
What is the SMILES notation for 2-[3-[(5R,11R)-14-benzyl-11-[(4-hydroxyphenyl)methyl]-5-(1H-indol-3-ylmethyl)-3,6,9,12,15-pentaoxo-1,4,7,10,13-pentazacyclopentadec-2-yl]propyl]guanidine?
The canonical SMILES for 2-[3-[(5R,11R)-14-benzyl-11-[(4-hydroxyphenyl)methyl]-5-(1H-indol-3-ylmethyl)-3,6,9,12,15-pentaoxo-1,4,7,10,13-pentazacyclopentadec-2-yl]propyl]guanidine is NC(N)=NCCCC1NC(=O)C(Cc2ccccc2)NC(=O)[C@@H](Cc2ccc(O)cc2)NC(=O)CNC(=O)[C@@H](Cc2c[nH]c3ccccc23)NC1=O.
What is the InChIKey of 2-[3-[(5R,11R)-14-benzyl-11-[(4-hydroxyphenyl)methyl]-5-(1H-indol-3-ylmethyl)-3,6,9,12,15-pentaoxo-1,4,7,10,13-pentazacyclopentadec-2-yl]propyl]guanidine?
The InChIKey is MFIQGOQLQIPLCK-VWKIIYCGSA-N. The full InChI is InChI=1S/C37H43N9O6/c38-37(39)40-16-6-11-28-34(50)46-31(19-24-20-41-27-10-5-4-9-26(24)27)33(49)42-21-32(48)43-29(18-23-12-14-25(47)15-13-23)35(51)45-30(36(52)44-28)17-22-7-2-1-3-8-22/h1-5,7-10,12-15,20,28-31,41,47H,6,11,16-19,21H2,(H,42,49)(H,43,48)(H,44,52)(H,45,51)(H,46,50)(H4,38,39,40)/t28?,29-,30?,31-/m1/s1.
What are the key properties of 2-[3-[(5R,11R)-14-benzyl-11-[(4-hydroxyphenyl)methyl]-5-(1H-indol-3-ylmethyl)-3,6,9,12,15-pentaoxo-1,4,7,10,13-pentazacyclopentadec-2-yl]propyl]guanidine?
2-[3-[(5R,11R)-14-benzyl-11-[(4-hydroxyphenyl)methyl]-5-(1H-indol-3-ylmethyl)-3,6,9,12,15-pentaoxo-1,4,7,10,13-pentazacyclopentadec-2-yl]propyl]guanidine has a molecular weight of 709.81 g/mol, XLogP of 0.02, 10 rotatable bonds, 9 hydrogen bond donors, and 7 hydrogen bond acceptors.
Where does this data come from?
All data for 2-[3-[(5R,11R)-14-benzyl-11-[(4-hydroxyphenyl)methyl]-5-(1H-indol-3-ylmethyl)-3,6,9,12,15-pentaoxo-1,4,7,10,13-pentazacyclopentadec-2-yl]propyl]guanidine is sourced from PubChem (CID 140752504), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).